Previous 10 |
This selection article continues a four-year ad hoc test of published studies that the Russell reconstitution generates excess risk-adjusted returns. In my prior three-year study from 2017, abnormal gains were identified from the annual June rebalancing and some profitable strategies ...
Biomea Fusion (BMEA): Q1 GAAP EPS of -$0.49 misses by $0.35.As of March 31, 2021, the Company had cash, cash equivalents, restricted cash, and investments of $57.5 million.Press Release For further details see: Biomea Fusion EPS misses by $0.35
-- Received $167 million in aggregate gross proceeds in April from initial public offering -- – Advancing lead oncology program BMF-219, a small molecule irreversible menin inhibitor, toward IND filing in second half of 2021 -- -- Mick Hitchcock, Ph.D., form...
Buying a stock right off its initial public offering (IPO) is a gamble, but daring investors know that it can pay off. Especially for companies that are expected to be growing right out of the gate, getting in during the market's initial feeding frenzy sometimes means buying a stock whe...
REDWOOD CITY, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically ...
The IPO market revved back to life with nine IPOs raising $5.4 billion, joined by crypto exchange Coinbase's direct listing. Pipeline activity held steady, with 10 IPOs, six SPACs, and one direct listing submitting initial filings. The first major direct listing on the Nasdaq, Coi...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 02:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-18 04:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Biomea Fusion, Inc. ("Biomea" or "the Company") (NASDAQ:BMEA). Investors who purchased Biomea securities are encouraged to obtain additional information...